Z99.2
Conditions
Interventions
Group 1: The present study utilizes a randomized crossover design involving a total of 50 patients, divided into two equally sized groups of 25 participants each.
Observation over eight weeks:
Group
Sponsors
Universitätsklinikum Marburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Dialysis patients Ability to give consent Sufficient knowledge of German
Exclusion criteria
Exclusion criteria: Epilepsy Significant visual impairment Dementia Paranoid schizophrenia Sedative medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to investigate the effect of VR exposure therapy on subjective well-being, measured using standardized quality of life questionnaires as the primary outcome parameters. The first phase allows for a controlled group comparison, while the second phase enables additional longitudinal insights into effectiveness, sustainability, and progression. | — |
Secondary
| Measure | Time frame |
|---|---|
| Usability of the VR application after two weeks, measured using the German version of the System Usability Scale (SUS). Trust in the technology, assessed with the Trust in Automation Scale, also after two weeks. | — |
Countries
Germany
Contacts
Public ContactIvica Grgic
Universitätsklinikum Marburg
Outcome results
None listed